Cigarette smoking affects urinary liver-type fatty acid-binding protein concentration in patients with early diabetic nephropathy [11]

Diabetes Care

Volumn 29, Issue 7, 2006, Pages 1717-

  Nakamura, Tsukasa ^a   Sugaya, Takeshi ^b   Koide, Hikaru ^c  

^a Shinmatsudo Central General Hospital   (Japan)

^b RIKEN   (Japan)

^c KOTO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID BINDING PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CIGARETTE SMOKING; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; KIDNEY FUNCTION; LETTER; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; SMOKING;

DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; SMOKING; SMOKING CESSATION;

EID: 33746425348     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0781     Document Type: Letter

References (6)

1. Orth SR, Schroeder T, Ritz E, Ferrari P: Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant 20:2414-2419, 2005
2. Orth SR: Smoking and the kidney. J Am Soc Nephrol 13:1663-1672, 2002
3. Phillips AO: The role of renal proximal tubular cells in diabetic nephropathy. Curr Diab Rep 3:491-496, 2003
4. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hikawa A, Hirano N, Hirata Y, Goto A, Omata M: Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med 143:23-30, 2004
5. Suzuki K, Babazono T, Murata H, Iwamoto Y: Clinical significance of urinary liver-type fatty acid-binding protein in patients with diabetic nephropathy. Diabetes Care 28:2038-2039, 2005
6. Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H: Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy. Diabetes Care 28:2728-2732, 2005